Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Center for Devices & Radiological Health

Executive Summary

CBER Medical Deputy Director David Feigal, MD, is named CDRH director. He will assume his duties during a one-month transition period. A replacement for his post at the Center for Biologics Evaluation & Research has not been named. Feigel joined FDA in 1992 as head of the Division of Antiviral Drug Products in the Center for Drug Evaluation & Research. He assumed his current position in the biologics center in September 1997
Advertisement

Related Content

FDA Device Center Director Departs; Feigal Oversaw Approval Of Cypher Stent
FDA Device Center Director Departs; Feigal Oversaw Approval Of Cypher Stent
Advertisement
UsernamePublicRestriction

Register

PS034114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel